Cardinal Health (CAH) Misses Q4 EPS by 43c, FY22 EPS Outlook Misses Consensus
Tweet
Share
E-mail
Get Alerts CAH Hot Sheet
Price: $225.38 -0.42%
Revenue Growth %: +4.2%
Financial Fact:
Cost of products sold: 30.45B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +4.2%
Financial Fact:
Cost of products sold: 30.45B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Cardinal Health (NYSE: CAH) reported Q4 EPS of $0.77, $0.43 worse than the analyst estimate of $1.20. Revenue for the quarter came in at $42.59 billion versus the consensus estimate of $40.39 billion.
GUIDANCE:
Cardinal Health sees FY2022 EPS of $5.60-$5.90, versus the consensus of $6.19.
For earnings history and earnings-related data on Cardinal Health (CAH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Corpay agrees to $100M FTC settlement over marketing practices
- Amneal gets FDA approval for lanreotide injection, launches immediately
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
